The HDA Research Foundation today announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program.
The HDA Research Foundation today announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program.
This month marks one year since the launch of Allied Against Opioid Abuse (AAOA), a national initiative to help address the nation’s prescription opioid abuse epidemic through education and awareness. In its first year, AAOA built a network of national and local partnerships, expanding its membership to include 16 national partners and more than 50 state and local partners.
On the release of the Energy and Commerce Committee’s review of opioid distribution in West Virginia, the Healthcare Distribution Alliance (HDA) released the following statement.
Following U.S. District Court Judge Katherine Polk Failla’s ruling today that New York’s Opioid Stewardship Act is unconstitutional, the Healthcare Distribution Alliance (HDA) issued the following statement.
Data published by the HDA Research Foundation reveal the changing market dynamics of the nearly $200 billion specialty pharmaceutical supply chain segment — and the important role HDA-member specialty pharmaceutical distributors play within it. The 2018 Specialty Pharmaceutical Distribution: Facts, Figures and Trends publication is based on an annual survey of HDA-member specialty distributors with sales greater than $1 billion for the 2017 (or most recently completed) fiscal year, and includes secondary data from leading healthcare organizations, such as IQVIA.
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269